The Union reports efficacy of its TB Vaccine Candidate

Vaccines |  News | 0 Comment | 30 Oct, 2019

International Union Against Tuberculosis and Lung Disease (The Union) headquartered in France, announces the Phase IIb T...Read more

NIH awards contracts to advance tuberculosis immunology research

Vaccines |  News | 0 Comment | 27 Sep, 2019

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarde...Read more

Alwaleed Philanthropies invests $5 M in global fight for vaccines

Vaccines |  News | 0 Comment | 02 Sep, 2019

Alwaleed Philanthropies, chaired by HRH Prince Alwaleed Bin Talal Bin Abdulaziz AlSaud, the global philanthropic fo...Read more

Crozet partners with PHV to develop Nipah virus vaccine

Vaccines |  News | 0 Comment | 28 Aug, 2019

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (P...Read more

Zuellig Pharma, NICVB, NIHE team up for accessibility of vaccines

Vaccines |  News | 0 Comment | 23 Apr, 2019

The National Institute of Vaccines and Medical Biologicals (NICVB), the National Institute of Hygiene and Epidemiology (...Read more

The Govt. of EG, US Energy Companies & Sanaria collaborate for malaria vaccine

Vaccines |  News | 0 Comment | 11 Apr, 2019

Sanaria Inc. and the Government of Equatorial Guinea last week signed an agreement that continues their joint ...Read more

Serum Institute launches biggest immunisation awareness drive in India

Vaccines |  News | 0 Comment | 22 Feb, 2019

Serum Institute of India (SII), vaccine manufacturer launched a nation-wide vaccination and immunisation campaign called...Read more

Vertex announces EC approval for ORKAMBI

Vaccines |  News | 0 Comment | 24 Jan, 2019

Global Biotechnology company, Vertex Pharmaceuticals has announced that the European Commission has granted approval of ...Read more

Exelixis announces USFDA approval of CABOMETYX

Vaccines |  News | 0 Comment | 16 Jan, 2019

Oncology focused biotechnology company, Exelixis has announced that USFDA has approved CABOMETYX tablets for patients wi...Read more

AstraZeneca’s Bevespi Aerosphere approved in the EU

Vaccines |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...Read more

FDA approves Sanofi & MSD’s VAXELIS™

Vaccines |  News | 0 Comment | 03 Jan, 2019

The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...Read more

Philip Gutry appointed as Chief Business Officer by Kronos Bio

Vaccines |  News | 0 Comment | 28 Nov, 2018

U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...Read more

Esco, Nuvonis enter into MoU to support novel vaccines in Asia

Vaccines |  News | 0 Comment | 04 Oct, 2018

Singapore - Esco Aster (Singapore) and Nuvonis Technologies (Austria) will sign a Memorandum of Understanding (MoU) for ...Read more

Enesi, Public Health England carry out R&D collaboration

Vaccines |  News | 0 Comment | 03 Oct, 2018

Singapore - Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dosevac...Read more

GSK TB vaccine shows promise in phII study

Vaccines |  News | 0 Comment | 30 Sep, 2018

Pharma giant GSK and Aeras reported that GSK’s candidate vaccine significantly reduced the incidence of pulmonary ...Read more

Rotavirus vaccine options expand with WHO’s prequalification

Vaccines |  News | 0 Comment | 28 Sep, 2018

PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL, ...Read more

Inovio Pharma, Geneone Lifesciences announce Ph1 study of Hep C vaccine

Vaccines |  News | 0 Comment | 13 Sep, 2018

Inovio Pharmaceuticals and Korea's GeneOne Life Science have announced that they have dosed the first patient in a Phase...Read more

India loses its vaccine export sheen

Vaccines |  News | 0 Comment | 14 Aug, 2018

India, once called as the vaccine capital, is slowly losing its sheen because of various reasons, primarily the aggressi...Read more